骨转移的前列腺癌患者的AMPK下调贝克林-1:一项观察性研究
Jiaxing Chen1, Lingyun Hu, Wangguang Zhou
1Department of Urology, The People's Hospital of Jiangshan, Quzhou , Zhejiang Province, China.
Medicine
|December 20, 2024
概括
前列腺癌骨转移是死亡的一个重要原因. 这项研究发现,AMPK-Beclin-1通路在减少前列腺癌扩散到骨方面发挥着至关重要的作用.
科学领域:
- 在瘤学瘤学.
- 分子生物学分子生物学
- 病理学 病理学 病理学
背景情况:
- 骨转移是前列腺癌的常见并发症,导致预后不佳和生活质量下降.
- 了解前列腺癌骨转移背后的分子机制对于开发有效的治疗方法至关重要.
研究的目的:
- 研究AMPK/Beclin-1信号通路在前列腺癌骨转移中的作用.
- 分析AMPK和Beclin-1表达在前列腺癌组织与骨转移之间的相关性.
主要方法:
- 从418名最初注册的患者中利用前列腺样本进行临床和病理分析.
- 进行免疫组织化学 (IHC) 检测以分析AMPK和Beclin-1信号通路的表达.
- 在46名前列腺癌骨转移患者和61名良性前列腺患者之间比较表达水平.
主要成果:
- 在前列腺癌与骨转移 (P < .05) 中发现贝克林-1和AMPK表达之间的负相关性.
- 在人类前列腺组织中观察到AMPK/Beclin-1信号的改变表达.
结论:
- AMPK-Beclin-1信号通路与前列腺癌转移到骨显著相关.
- 这种途径似乎起着保护作用,减少前列腺癌扩散到骨组织.
相关概念视频
PI3K/mTOR/AKT Signaling Pathway
3.4K
The mammalian target of rapamycin (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1 (mTORC1) and mTOR complex 2 (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast, mTORC2 consists of a...
3.4K
mTOR Signaling and Cancer Progression
3.7K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
3.7K
cAMP-dependent Protein Kinase Pathways
6.1K
Cyclic Adenosine Monophosphate (cAMP) is an essential second messenger that activates protein kinase A (PKA) and regulates various biological processes. A single epinephrine molecule binds to GPCR and activates several heterotrimeric G proteins, each stimulating multiple adenylyl cyclase, amplifying the signal, and synthesizing large numbers of cAMP molecules. Small changes in cAMP concentration affect PKA activity. The binding of four cAMP molecules induces a conformational change in PKA,...
6.1K
Protein Kinases and Phosphatases
13.0K
Proteins undergo chemical modifications that trigger changes in the charge, structure, and conformation of the proteins. Phosphorylation, acetylation, glycosylation, nitrosylation, ubiquitination, lipidation, methylation, and proteolysis are various protein modifications that regulate protein activity. Such modifications are usually enzyme-driven.
Protein kinases
Many proteins in the cell are regulated by phosphorylation, the addition of a phosphate group. A family of enzymes called kinases...
Protein kinases
Many proteins in the cell are regulated by phosphorylation, the addition of a phosphate group. A family of enzymes called kinases...
13.0K
Regulation of Angiogenesis and Blood Supply
2.5K
Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits. Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl...
2.5K


